Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer and the genetic revolution.

B J Warner1, G A McArthur

  • 1Peter MacCallum Cancer Institute, Melbourne, Victoria.

Australian Family Physician
|November 15, 2001
PubMed
Summary

The Human Genome Project offers insights into genetic cancer causes, enabling personalized risk prediction and tailored cancer treatments. This genetic information will guide optimal treatment decisions for both prevention and existing conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAF<sup>V600</sup> mutation-positive melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma.

Scientific reports·2018
Same author

Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Area of Science:

  • Genomics and molecular biology
  • Cancer research and oncology

Background:

  • The Human Genome Project is nearing completion, providing a detailed molecular map.
  • Cancer, a genetic disease, can be better understood and treated using genome data.

Purpose of the Study:

  • To examine the potential outcomes of new technologies for cancer.
  • To explore advancements in cancer prediction, profiling, and individualized treatments.

Main Methods:

  • Analysis of potential applications of genome information.
  • Review of emerging technologies in cancer diagnostics and therapeutics.

Main Results:

  • Genome data facilitates identification of individuals at high risk for cancer.
  • Technologies enable personalized cancer treatment strategies.

Conclusions:

  • Clinicians can leverage genome information for proactive cancer risk assessment.
  • Genetic insights will guide the selection of the most effective treatments for existing cancers.

Related Experiment Videos